A series of regulatory filings and interim reports published in late August and September 2026 provides verifiable operational data on key players across China’s medical robotics and clinical automation sectors. During this disclosure window, Edge Medical reported rapid top-line expansion supported by overseas equipment shipments alongside an initiative to prepare for an onshore A-share public offering. In contrast, Han’s Robot recorded single-digit top-line growth while gaining direct access to mainland retail and institutional capital through its inclusion in the Southbound Stock Connect. Concurrently, Iron Tech updated its hospital customer metrics, confirming deep penetration across China’s top-tier healthcare institutions. Rather than demonstrating a uniform sector-wide trajectory, these disclosures document distinct commercial tempos, diverging geographic focuses, and varying capital market mechanisms across the medical robotics landscape.
Edge Medical: Revenue Expansion Driven by Overseas Deliveries
On September 23, 2026, Edge Medical disclosed its 2026 interim report covering operational and financial performance for the first half of the year. According to the company’s interim report, revenue reached RMB 319.3 million during the reporting period, representing a year-on-year increase of 113.8% compared to the same period in 2025.
This revenue surge coincided with substantial additions to the company’s clinical robotics footprint abroad. The company disclosed that as of June 30, 2026, its cumulative global installations and deliveries reached 158 surgical robots. During the first half of 2026, the company completed 58 new installations or deliveries worldwide, consisting of 9 units in the domestic market and 49 units overseas. Overseas shipments accounted for the vast majority of all units installed or delivered by the company during the first six months of 2026.
The volume expansion occurred alongside strict stability in organizational headcount. Edge Medical reported that it employed 604 full-time employees as of June 30, 2026, compared to 602 employees as of December 31, 2025. The net addition of 2 employees across the six-month period demonstrates that the company fulfilled 58 unit deliveries and achieved triple-digit revenue growth without expanding its direct organizational workforce.
Edge Medical: Initiating Mainland A-Share Listing Pipeline
Beyond its interim commercial performance, the company moved to expand its access to domestic mainland equity financing. On September 11, 2026, Edge Medical announced that it was exploring a preliminary proposal regarding the proposed issuance of RMB-denominated ordinary shares to initiate a listing on the domestic A-share market.
To advance the A-share listing process, the company disclosed that it had engaged a pre-listing tutoring agency. The formal registration application for pre-listing tutoring was submitted to the regulatory authorities on September 11, 2026. This filing represents a preparatory step toward potentially establishing a dual-listed capital structure across Hong Kong and mainland China.
Han’s Robot: Flat Revenue Growth and Southbound Stock Connect Entry
Han’s Robot released its 2026 interim report on the Hong Kong Stock Exchange on September 22, 2026, detailing financial results for the six months ended June 30, 2026. According to the company’s disclosure, total revenue for the reporting period reached RMB 174.1 million, an increase of 0.6% from RMB 173.0 million reported for the corresponding period of 2025.
While top-line expansion remained modest, Han’s Robot secured broader trading access for mainland investors through cross-border trading infrastructure. On September 4, 2026, the Shanghai Stock Exchange announced an adjustment to the list of eligible securities under the Southbound Stock Connect pursuant to the Shanghai-Hong Kong Stock Connect business implementation rules. Under this adjustment, the exchange confirmed that Han’s Robot (stock code: 01021.HK) was added to the Southbound Stock Connect eligible list effective on the next trading day. This regulatory inclusion permits eligible investors in mainland China to trade the company’s Hong Kong-listed shares directly through mainland brokerages.
Han’s Robot: Workforce Baseline Updates
Alongside its financial performance, Han’s Robot updated its total personnel figures in its interim disclosure. According to the company’s interim report, total group headcount stood at 658 employees as of June 30, 2026.
This figure updates the site’s previously listed baseline of 500+ employees for the company. The disclosed 658 headcount indicates a higher base of staffing than the site’s previous baseline, contrasting with the modest 0.6% revenue growth reported by the company over the same interim timeframe.
Iron Tech: Institutional Penetration in Tier-Three Hospitals
Separately, Iron Tech provided operational progress on its domestic institutional footprint in its 2026 semi-annual report published on August 25, 2026. The company reported that as of the end of the reporting period, its products had achieved coverage across more than 1,000 domestic healthcare and medical institutions.
The report further disclosed that this institutional total included over 600 Class III Grade A hospitals across China. Class III Grade A facilities represented the majority of the company’s domestic institutional client network. This establishes an extensive installed base within the country’s highest tier of medical facilities for the company’s healthcare products.
Patterns & Outlook
A comparative review of the late August and September 2026 disclosures shows marked contrasts in commercial momentum and capital strategy among medical robotics and healthcare technology participants.
First, top-line performance reflects substantial variance between sub-sectors according to each company’s disclosures. Edge Medical reported RMB 319.3 million in revenue with 113.8% year-on-year growth, whereas Han’s Robot disclosed RMB 174.1 million with 0.6% growth against RMB 173.0 million in the prior-year period.
Second, the geographic composition of commercial deliveries indicates where volume is materializing. Edge Medical’s first-half volume relied overwhelmingly on international demand, delivering 49 robots overseas compared to 9 robots domestically. Conversely, Iron Tech maintained its scale inside the domestic medical infrastructure, surpassing 1,000 healthcare facilities including more than 600 Class III Grade A hospitals.
Finally, companies are tapping into domestic mainland capital via distinct legal and market structures. Edge Medical initiated the regulatory pipeline for a primary onshore A-share public listing by filing its tutoring registration on September 11, 2026. In parallel, Han’s Robot gained direct access to mainland liquidity through Southbound Stock Connect inclusion effective the next trading day following the announcement, without initiating a separate domestic listing. As companies advance through the second half of 2026, installation conversion rates and capital access mechanisms will remain the primary metrics determining their commercial durability.